IDH2-MUTANT GLIOMA

Clinical trials for IDH2-MUTANT GLIOMA explained in plain language.

Never miss a new study

Get alerted when new IDH2-MUTANT GLIOMA trials appear

Sign up with your email to follow new studies for IDH2-MUTANT GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

New drug combo tested for Hard-to-Treat brain tumors

Disease control Ongoing

This study is testing a new combination of two drugs, vorasidenib and temozolomide, for people with a specific type of brain tumor called an IDH-mutant glioma. The first part of the study aims to find the safest and most effective dose. The second part will see how well this dose…

Matched conditions: IDH2-MUTANT GLIOMA

Phase: PHASE1, PHASE2 • Sponsor: Institut de Recherches Internationales Servier • Aim: Disease control

Last updated Apr 04, 2026 07:50 UTC

IDH2-MUTANT GLIOMA

Get alerted when new IDH2-MUTANT GLIOMA trials appear

New drug combo tested for Hard-to-Treat brain tumors